These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2496221)

  • 1. An electron microscopic study of alterations in the morphology and permeability of purified Mycobacterium leprae.
    Prabhakaran K; Job CK; Harris EB; McCormick GT
    J Basic Microbiol; 1989; 29(1):41-8. PubMed ID: 2496221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-induced changes in viability, diphenoloxidase and permeability of Mycobacterium leprae.
    Prabhakaran K; Harris EB
    Microbios; 1985; 43(172):7-15. PubMed ID: 3929029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible method for improving the efficacy of dapsone.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Experientia; 1980 Dec; 36(12):1350-1. PubMed ID: 6781921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inhibitors of host-tissue origin in Mycobacterium leprae.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Lepr India; 1979 Jul; 51(3):348-57. PubMed ID: 117257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electron microscopic observations of cell wall and cytoplasmic membrane in murine and human leprosy bacilli.
    Hirata T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):433-40. PubMed ID: 3900250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the cell structures of Mycobacterium leprae and M. tuberculosis using the electron microscopy freeze-substitution technique.
    Takade A; Umeda A; Matsuoka M; Yoshida S; Nakamura M; Amako K
    Microbiol Immunol; 2003; 47(4):265-70. PubMed ID: 12801063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.
    Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL
    Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium leprae and phenoloxidase activity.
    Kim SJ; Ishaque M; Kato L
    Microbios; 1978; 22(89-90):143-53. PubMed ID: 113650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
    Rastogi N; Cadou S; Hellio R
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid oxidation and the beta-oxidation complex in Mycobacterium leprae and two axenically cultivable mycobacteria that are pathogens.
    Wheeler PR; Bulmer K; Ratledge C
    J Gen Microbiol; 1991 Apr; 137(4):885-93. PubMed ID: 1856682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution shadowing of Mycobacterium leprae.
    Kumar V
    Biotech Histochem; 2004; 79(5-6):197-201. PubMed ID: 15764287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
    Chang YT
    Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary dapsone resistance as assessed by uptake of labelled thymidine by the macrophage resident Mycobacterium leprae.
    Thakur M; Vaishnavi C; Ganguly NK; Kaur S; Kumar B
    Indian J Lepr; 1989 Oct; 61(4):437-41. PubMed ID: 2695575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual effects of reducing agents on 0-diphenoloxidase of Mycobacterium leprae.
    Prabhakaran K
    J Bacteriol; 1971 Sep; 107(3):787-9. PubMed ID: 4999415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. o-Diphenoloxidase of Mycobacterium leprae separated from infecected armadillo tissues.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Infect Immun; 1975 Aug; 12(2):267-9. PubMed ID: 807522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.